Novanta NOVT Medical Solutions — Restructuring Costs
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Novanta in its filing.
Tagged under the XBRL concept us-gaap:RestructuringCosts.
The official record: Novanta’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Novanta's medical solutions — restructuring costs.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Novanta's medical solutions — restructuring costs?
- Novanta (NOVT) reported medical solutions — restructuring costs of $506K in Q1 2026.
- How has Novanta's medical solutions — restructuring costs changed year-over-year?
- Novanta's medical solutions — restructuring costs increased by 517.1% year-over-year, from $82K to $506K.
- What is the long-term trend for Novanta's medical solutions — restructuring costs?
- Over 4 years (2021 to 2025), Novanta's medical solutions — restructuring costs has grown at a 73.7% compound annual growth rate (CAGR), from $813K to $7.41M.
- What does medical solutions — restructuring costs mean?
- Expenses incurred to reorganize, consolidate, or streamline operations within the Medical Solutions segment to improve long-term efficiency. These costs typically include severance, facility closures, and other exit activities associated with strategic business realignment.